Abarca Rozas Bastian, Mestas Rodríguez Manuel, Widerström Isea Jorge, Lobos Pareja Beatriz, Vargas Urra Jocelyn
Facultad de Medicina, Universidad San Sebastián, Santiago, Chile. Email:
Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile. ORCID: 0000-0001-9699-6137.
Medwave. 2020 Jun 9;20(5):e7928. doi: 10.5867/medwave.2020.05.7928.
Acute kidney injury is a syndrome characterized by a sudden, sustained, and potentially reversible decrease in glomerular filtration rate and tubular function, which globally impacts renal function. It comprises of a series of events starting with the presence of risk factors, then evolving towards acute kidney injury progression, characterized by stress, injury, and renal failure, culminating with either the use of renal replacement therapy or death. Currently, the use of biomarkers that differentiate between the initial functional deterioration and late-onset structural damage of the kidney enables the clinician to perform an early diagnosis and indicate treatment before the stages of acute kidney injury progression are established, thus increasing survival rates.
急性肾损伤是一种以肾小球滤过率和肾小管功能突然、持续且可能可逆的下降为特征的综合征,这会对整体肾功能产生影响。它包括一系列事件,始于危险因素的存在,然后朝着急性肾损伤进展发展,其特征为应激、损伤和肾衰竭,最终以使用肾脏替代疗法或死亡告终。目前,使用能够区分肾脏初始功能恶化和迟发性结构损伤的生物标志物,使临床医生能够在急性肾损伤进展阶段确立之前进行早期诊断并指明治疗方法,从而提高生存率。